Portage Biotech Liabilities 2024

Portage Biotech Aktienanalyse

What does Portage Biotech do?

Portage Biotech Inc is an international biotechnology company based in Canada. The company was established in 2015 as a holding company and took control of the stock of Biohaven Pharmaceutical Holding Company. Portage Biotech operates in various locations, including Canada, the US, and Europe. The business model of Portage Biotech is based on identifying promising new technologies and creating companies that utilize these technologies. The company employs a strategic investment strategy, acquiring stakes in promising biotechnology companies and working closely with them to bring their products and therapies to market. Another strategy of Portage Biotech is the establishment of innovation centers in different countries. This involves bringing together highly skilled personnel and cutting-edge technologies under one roof to create innovative products and solutions that can be brought to the global market. The company also operates in several business areas, including medical research and development. In this field, Portage Biotech works on developing new therapies, particularly in the field of cancer research. Additionally, the company has a division for medical diagnostics, where innovative testing procedures are developed to contribute to early disease detection. Another important business area for Portage Biotech is the manufacturing of biopharmaceuticals, which are drugs based on biological agents. The company collaborates closely with other biotechnology companies to bring innovative products to the market. Portage Biotech has already successfully implemented a number of promising projects, including the development of therapies for cancer, Alzheimer's, and Parkinson's. The company also has promising biosimilars and biosuperior products in the pipeline that could revolutionize the market. To successfully execute these projects, Portage Biotech has assembled an impressive leadership team. The company has an experienced team of scientists, managers, and professionals who are dedicated to finding the best solutions for the challenges of the biotechnology industry. Overall, Portage Biotech is an innovative company that focuses on the discovery and promotion of promising new technologies. The company has already achieved an impressive track record and has the potential to play a revolutionary role in the field of biotechnology. Portage Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Portage Biotech's Liabilities

Portage Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Portage Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Portage Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Portage Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Portage Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Portage Biotech stock

What is the level of liabilities of Portage Biotech this year?

Portage Biotech has a debt balance of 3.76 M USD this year.

What were the liabilities of Portage Biotech compared to the previous year?

The liabilities of Portage Biotech have increased by -94.89% dropped compared to the previous year.

What are the consequences of high debt for investors of Portage Biotech?

High liabilities can pose a risk for investors of Portage Biotech, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Portage Biotech?

Low liabilities mean that Portage Biotech has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Portage Biotech affect the company?

An increase in liabilities of Portage Biotech can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Portage Biotech affect the company?

A decrease in the liabilities of Portage Biotech can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Portage Biotech?

Some factors that can influence the liabilities of Portage Biotech include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Portage Biotech so important for investors?

The liabilities of Portage Biotech are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Portage Biotech take to modify the liabilities?

To change its liabilities, Portage Biotech can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Portage Biotech pay?

Over the past 12 months, Portage Biotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Portage Biotech is expected to pay a dividend of 0 USD.

What is the dividend yield of Portage Biotech?

The current dividend yield of Portage Biotech is .

When does Portage Biotech pay dividends?

Portage Biotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Portage Biotech?

Portage Biotech paid dividends every year for the past 0 years.

What is the dividend of Portage Biotech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Portage Biotech located?

Portage Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Portage Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Portage Biotech from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Portage Biotech pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Portage Biotech in the year 2023?

In the year 2023, Portage Biotech distributed 0 USD as dividends.

In which currency does Portage Biotech pay out the dividend?

The dividends of Portage Biotech are distributed in USD.